Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
10.65
+2.08 (24.27%)
Jun 6, 2025, 2:47 PM - Market open

Addex Therapeutics Cash Flow Statement

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
7.06-10.56-20.8-15.35-12.86
Upgrade
Depreciation & Amortization
0.190.010.010.350.38
Upgrade
Loss (Gain) on Equity Investments
2.18----
Upgrade
Stock-Based Compensation
0.180.280.681.341.46
Upgrade
Other Operating Activities
-0.180.290.2-0.280.66
Upgrade
Change in Accounts Receivable
0.130.45-0.27-0.260.05
Upgrade
Change in Accounts Payable
-1.15-0.61-0.430.88-1.59
Upgrade
Change in Unearned Revenue
-0.040.32--0.82-0.46
Upgrade
Change in Other Net Operating Assets
-0.180.060.86-0.570.17
Upgrade
Operating Cash Flow
-5.37-7.99-16.44-14.71-12.18
Upgrade
Capital Expenditures
-0-0.01-0-0.03-0.06
Upgrade
Investment in Securities
--00-
Upgrade
Other Investing Activities
4.65----
Upgrade
Investing Cash Flow
4.65-0.010-0.03-0.06
Upgrade
Long-Term Debt Repaid
-0.07-0.28-0.29-0.31-0.37
Upgrade
Net Debt Issued (Repaid)
-0.07-0.28-0.29-0.31-0.37
Upgrade
Issuance of Common Stock
0.242.351.6813.960.72
Upgrade
Repurchase of Common Stock
-0.03-0.05-0.31-0.39-
Upgrade
Other Financing Activities
-0.043.242.023.14-0.31
Upgrade
Financing Cash Flow
0.15.263.116.40.05
Upgrade
Foreign Exchange Rate Adjustments
0.1-0.36-0.20.12-0.65
Upgrade
Net Cash Flow
-0.52-3.09-13.531.79-12.84
Upgrade
Free Cash Flow
-5.37-8-16.44-14.74-12.24
Upgrade
Free Cash Flow Margin
-1310.80%-494.64%-1137.59%-467.34%-315.52%
Upgrade
Free Cash Flow Per Share
-0.06-0.11-0.36-0.43-0.46
Upgrade
Cash Interest Paid
0.010.020.050.060.07
Upgrade
Levered Free Cash Flow
-3.01-0.99-6.19-8.2-7.85
Upgrade
Unlevered Free Cash Flow
-3.01-0.99-6.17-8.16-7.81
Upgrade
Change in Net Working Capital
1.66-0.130.270.131.94
Upgrade
Updated Nov 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q